Skip to main content

Advertisement

Table 3 Characteristics of the RECs across the various European countries involved in GenOSept

From: Methodological challenges in European ethics approvals for a genetic epidemiology study in critically ill patients: the GenOSept experience

Characteristic Median (IQR) or n (%)
[Range]
No of ICUs per country 7 (2–15)
[1–28]
Countries with centralized (national/regional) REC only 8 (44.4%)
Countries with local REC only 7 (38.9%)
Countries with both centralized and local REC 3 (16.7%)
Countries with paper application process 17 (94.4%)
Countries with online application process 1 (5.6%)
Medical members of REC 18 (100%)
Lay and Legal members of REC 13 (72.2%)
Lay but no Legal members of REC 1 (5.6%)
Approval at all units within country 14 (77.8%)
Approval at some units within country 3 (16.7%)
No approval at country 1 (5.6%)
Application process duration (months) 1.5 (1–7)
[1–24]
Additional information or modification required 7 (38.9%)
Countries with National guidelines for research in critical care 9 (50%)
  1. IQR inter-quartile range, n absolute number, % percentage